InMed Pharmaceuticals's total assets for Q2 2024 were $15.26M, an increase of 39.74% from the previous quarter. INM total liabilities were $2.48M for the fiscal quarter, a 85.42% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.